astigmatism
Conditions
Interventions
Group 2:Toric ICL surgery
Sponsors
Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical University, Chongqing, China
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Aged at least 18 years with stable refraction for at least 1 year, myopia with a minimum astigmatism of 1.0 D,corrected distant visual acuity (CDVA) of 20/30 or better, healthy tear film and ocular surface, absence of corneal ectatic diseases, corneal scars and retinal pathology. Patients using soft and rigid contact lenses were instructed to discontinue at least for 2 and 4 weeks, respectively. For Toric ICL patients, anterior chamber depth was more than 2.8 mm and Endothelial cell was above 2000 cells/mm2. As well for FS-LASIK patients, central corneal thickness was more than 500 um and residual stroma more than 280um.;Inclusion criteria: Aged at least 18 years with stable refraction for at least 1 year, myopia with a minimum astigmatism of 1.0 D,corrected distant visual acuity (CDVA) of 20/30 or better, healthy tear film and ocular surface, absence of corneal ectatic diseases, corneal scars and retinal pathology. Patients using soft and rigid contact lenses were instructed to discontinue at least for 2 and 4 weeks, respectively. For Toric ICL patients, anterior chamber depth was more than 2.8 mm and Endothelial cell was above 2000 cells/mm2. As well for FS-LASIK patients, central corneal thickness was more than 500 um and residual stroma more than 280um.;Inclusion criteria: Aged at least 18 years with stable refraction for at least 1 year, myopia with a minimum astigmatism of 1.0 D,corrected distant visual acuity (CDVA) of 20/30 or better, healthy tear film and ocular surface, absence of corneal ectatic diseases, corneal scars and retinal pathology. Patients using soft and rigid contact lenses were instructed to discontinue at least for 2 and 4 weeks, respectively. For Toric ICL patients, anterior chamber depth was more than 2.8 mm and Endothelial cell was above 2000 cells/mm2. As well for FS-LASIK patients, central corneal thickness was more than 500 um and residual stroma more than 280um.;Inclusion criteria: Aged at least 18 years with stable refraction for at least 1 year, myopia with a minimum astigmatism of 1.0 D,corrected distant visual acuity (CDVA) of 20/30 or better, healthy tear film and ocular surface, absence of corneal ectatic diseases, corneal scars and retinal pathology. Patients using soft and rigid contact lenses were instructed to discontinue at least for 2 and 4 weeks, respectively. For Toric ICL patients, anterior chamber depth was more than 2.8 mm and Endothelial cell was above 2000 cells/mm2. As well for FS-LASIK patients, central corneal thickness was more than 500 um and residual stroma more than 280um.;Inclusion criteria: Aged at least 18 years with stable refraction for at least 1 year, myopia with a minimum astigmatism of 1.0 D,corrected distant visual acuity (CDVA) of 20/30 or better, healthy tear film and ocular surface, absence of corneal ectatic diseases, corneal scars and retinal pathology. Patients using soft and rigid contact lenses were instructed to discontinue at least for 2 and 4 weeks, respectively. For Toric ICL patients, anterior chamber depth was more than 2.8 mm and Endothelial cell was above 2000 cells/mm2. As well for FS-LASIK patients, central corneal thickness was more than 500 um and residual stroma more than 280um.
Exclusion criteria
Exclusion criteria: Patients with eye trauma, corneal disease, retinal disease and a history of ocular surgery were excluded;Exclusion criteria: Patients with eye trauma, corneal disease, retinal disease and a history of ocular surgery were excluded;Exclusion criteria: Patients with eye trauma, corneal disease, retinal disease and a history of ocular surgery were excluded;Exclusion criteria: Patients with eye trauma, corneal disease, retinal disease and a history of ocular surgery were excluded;Exclusion criteria: Patients with eye trauma, corneal disease, retinal disease and a history of ocular surgery were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| astigmatism; | — |
Countries
China
Contacts
Public ContactJian Ye;Jian Ye;Jian Ye;Jian Ye;Jian Ye ;;;;
Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical University, Chongqing, China;Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical University, Chongqing, China;Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical University, Chongqing, China;Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical Universit
Outcome results
None listed